Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 18 May 2018
At a glance
- Drugs Dendritic cell vaccines (Primary) ; Pidilizumab (Primary)
- Indications Multiple myeloma
- Focus Pharmacodynamics
- 10 May 2018 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2019.
- 08 Dec 2015 Results (n=22) presented at the 57th Annual Meeting and Exposition of the American Society of Hematology.
- 22 Nov 2013 Planned end date changed from 1 Mar 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov.